<VariationArchive VariationID="2685545" VariationName="GRCh37/hg19 16p13.3(chr16:3788869-3849208)x1" VariationType="copy number loss" Accession="VCV002685545" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-04" DateCreated="2024-01-26" MostRecentSubmission="2024-01-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2846580" VariationID="2685545">
      <GeneList>
        <Gene Symbol="CREBBP" FullName="CREB binding protein" GeneID="1387" HGNC_ID="HGNC:2348" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3725054" stop="3880713" display_start="3725054" display_stop="3880713" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3775054" stop="3930120" display_start="3775054" display_stop="3930120" Strand="-" />
          </Location>
          <OMIM>600140</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CREBBP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CREBBP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 16p13.3(chr16:3788869-3849208)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="3788869" innerStop="3849208" display_start="3788869" display_stop="3849208" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 16p13.3(chr16:3788869-3849208)x1 AND not provided" Accession="RCV003483262" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-01-26" MostRecentSubmission="2024-01-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7904266" SubmissionDate="2024-01-03" DateLastUpdated="2024-01-26" DateCreated="2024-01-26">
        <ClinVarSubmissionID localKey="C10925|not provided|copy:1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004230177" DateUpdated="2024-01-26" DateCreated="2024-01-26" Type="SCV" Version="1" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The copy number loss of 16p13.3 involves multiple exons (NM_004380.3) of an intragenic portion of CREBBP (OMIM 600140). Haploinsufficiency of CREBBP is associated with Rubinstein-Taybi syndrome 1 (RSTS1; OMIM 180849, Stevens 2019, Cross 2020, Perez-Grijalba 2019). There are no similar copy number losses of this region in the general populations of the Database of Genomic Variants. Thus, the classification of this copy number variant (CNV) is pathogenic. References: Cross et al., Am J Med Genet A. 2020 Nov;182(11):2508-2520. PMID: 32827181 Perez-Grijalba et al., Mol Genet Genomic Med. 2019 Nov;7(11):e972. PMID: 31566936 Stevens et al., GeneReviews 2019 Aug. PMID: 20301699</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" innerStart="3788869" innerStop="3849208" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108155</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7904266" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

